New atherosclerosis vaccine gives promising results

May 06, 2010

A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis. By producing a vaccine against the T cell receptors, the researchers have managed to inhibit the development of atherosclerosis in animals. The study is presented online in the distinguished periodical Journal of Experimental Medicine and is expected to be of considerable significance to the future treatment of atherosclerosis, heart attack and stroke.

Cholesterol is transported in the blood in LDL particles, which are a kind of fat drops that can accumulate in the walls of . LDL activates the immune defence and triggers an inflammation in the blood vessels that leads to atherosclerosis (also known as arteriosclerosis). When the atherosclerotic plaque finally ruptures, a blood clot is formed that in turn can cause a heart attack or stroke.

It was previously thought that the inflammation in the blood vessels arises when the react to oxidised LDL particles located in the atherosclerotic plaque. Now, however, the team at Karolinska Institutet has found that the opposite is true, namely that the T cells react to components in the normal LDL particles, and that they no longer recognise LDL once it has been oxidised.

"Since reactions to LDL can be dangerous, T cells are normally held in check by inhibitory signals," says Professor Göran K Hansson, who led the study. "The body's own control works well as long as the LDL keeps to the blood, liver and lymph glands. But when it accumulates in the artery wall, this inhibition is no longer enough, the T cells are activated and an inflammation arises."

Together with his research group at Karolinska Institutet he now presents a new principle for inhibiting . Vaccination against the receptor that the T cells use to recognise LDL can block the and reduce the disease by between 60 and 70 per cent. The vaccine has been successfully tested on animals and the researchers are now hoping to see if it can be developed into a treatment for patients with a high risk of myocardial infarction and stroke.

The researchers also now believe that their results explain why antioxidants are ineffective against cardiovascular disease when they have been tested in large clinical studies.

"If one takes antioxidants, one simply prevents the oxidation of LDL," says Professor Hansson. "It retains its ability to activate the T cells, and so the inflammation in the blood vessels can increase. This could give the opposite results to what one was hoping for."

Explore further: Medicinal GPS: DNA nanotechnology-based approach allows injected drugs to find tumor sites

More information: "Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis", Andreas Hermansson, Daniel F.J. Ketelhuth, Daniela Strodthoff, Marion Wurm, Emil M. Hansson, Antonino Nicoletti, Gabrielle Paulsson-Berne & Göran K. Hansson, Journal of Experimental Medicine, online 3 May 2010, doi:10.1084/jem.20092243

add to favorites email to friend print save as pdf

Related Stories

Inflammation worsens danger due to atherosclerosis

Jan 22, 2009

Current research suggests that inflammation increases the risk of plaque rupture in atherosclerosis. The related report by Ovchinnikova et al, "T cell activation leads to reduced collagen maturation in atherosclerotic plaques ...

Bad cholesterol inhibits the breakdown of peripheral fat

Nov 20, 2008

The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of ...

New blood test reveals risk for metabolic syndrome

May 20, 2008

University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic ...

Genes that protect against atherosclerosis identified

Mar 14, 2008

One way of combating atherosclerosis is to reduce levels of “bad cholesterol” in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring about this beneficial ...

Recommended for you

How Alzheimer's peptides shut down cellular powerhouses

19 hours ago

The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered ...

User comments : 0